Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis
- 9 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Urology
- Vol. 28 (1), 117-122
- https://doi.org/10.1007/s00345-009-0432-y
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Proteomic analysis for human urinary proteins associated with arsenic intoxicationProteomics – Clinical Applications, 2008
- Cell cycle kinases in cancerCurrent Opinion in Genetics & Development, 2007
- Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladderBJU International, 2005
- Amplification and overexpression of prosaposin in prostate cancerGenes, Chromosomes and Cancer, 2005
- T-Cadherin Negatively Regulates the Proliferation of Cutaneous Squamous Carcinoma CellsJournal of Investigative Dermatology, 2005
- MULTIFOCAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND UPPER URINARY TRACT: MOLECULAR SCREENING OF CLONAL ORIGIN BY CHARACTERIZING CD44 ALTERNATIVE SPLICING PATTERNSJournal of Urology, 2004
- Urine cytology, tumour markers and bladder cancerBJU International, 1998
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Cancer‐Related urinary proteinase inhibitor, EDC1: A new method for its isolation and evidence for multiple formsJournal of Cellular Biochemistry, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976